# Interventions for Reading Disabilities in NF1

> **NCT02964884** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Vanderbilt University** · enrollment: 120 (estimated)

## Conditions studied

- Neurofibromatosis Type 1
- Learning Disability
- Reading Disability
- NF1

## Interventions

- **DRUG:** Lovastatin
- **BEHAVIORAL:** reading tutoring intervention
- **DRUG:** Placebo Oral Tablet
- **BEHAVIORAL:** Other Academic "sham" tutoring

## Key facts

- **NCT ID:** NCT02964884
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-11
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02964884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02964884, "Interventions for Reading Disabilities in NF1". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02964884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*